Metasurface Plasmon Resonance Biosensor Enhanced with Dual Gold Nanoparticles for the Ultrasensitive Quantitative Detection of C-Reactive Protein
Source abstract
Abstract
The pursuit of cutting-edge diagnostic systems capable of detecting biomarkers with exceptional sensitivity and precision is crucial for the timely and accurate monitoring of inflammatory responses. In this study, we introduce a dual gold nanoparticle-enhanced metasurface plasmon resonance (Bi-MSPR) biosensor for the ultrasensitive detection of C-reactive protein (CRP). The Bi-MSPR sensor is constructed upon a nanocup array chip with gradient-free electron density, where an innovative metasurface structure is built using a PEI-immobilized dual-gold nanoparticle amplification system. This strategy greatly amplifies the local free electric field, resulting in a signal enhancement exceeding 10-fold, with a detection limit of 0.04 ng/mL for CRP in buffer solutions and 0.017 μg/mL for serum samples. Clinical validation demonstrates a 95.83% detection rate with no cross-reactivity, highlighting the sensor's remarkable specificity and sensitivity for CRP detection. The Bi-MSPR biosensor thus represents a rapid, sensitive, and specific diagnostic tool for CRP detection.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Plasmonic and Surface Plasmon Research · Biosensors and Analytical Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
College of Life Science and Technology, State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases
Huazhong University of Science and Technology
College of Life Science and Technology, Mudanjiang Normal University
School of Materials and Chemistry, China University of Geosciences
Biosensor R&D Department
Liangzhun (Wuhan) Life Technology Co., Ltd.
School of Food Science and Pharmaceutical Engineering, Nanjing Normal University
Funding
National Natural Science Foundation of China
References (26)
Show source-provided references
1. McFadyen J. D. · 2020 · 49910.1007/978-3-030-41769-7_20 ↗
2. 10.3390/cancers1207196610.3390/cancers12071966 ↗
3. 10.1016/j.talanta.2020.12172510.1016/j.talanta.2020.121725 ↗
4. 10.1016/j.apsadv.2022.10034310.1016/j.apsadv.2022.100343 ↗
5. 10.1016/j.aca.2022.34012910.1016/j.aca.2022.340129 ↗
6. 10.1364/OE.47078610.1364/OE.470786 ↗
7. 10.1002/adfm.20170600610.1002/adfm.201706006 ↗
8. 10.1515/nanoph-2018-002310.1515/nanoph-2018-0023 ↗
9. 10.1016/j.snb.2017.07.03910.1016/j.snb.2017.07.039 ↗
10. 10.1002/adhm.20240109710.1002/adhm.202401097 ↗
11. 10.1002/adfm.20230614510.1002/adfm.202306145 ↗
12. 10.1016/j.mtbio.2022.10044410.1016/j.mtbio.2022.100444 ↗
13. 10.1016/j.cej.2024.15589610.1016/j.cej.2024.155896 ↗
14. 10.1016/j.bios.2020.11268510.1016/j.bios.2020.112685 ↗
15. 10.1002/adfm.20231448110.1002/adfm.202314481 ↗
16. 10.1002/smll.20180525110.1002/smll.201805251 ↗
17. 10.1016/j.crci.2017.11.01010.1016/j.crci.2017.11.010 ↗
18. 10.1155/2024/935082210.1155/2024/9350822 ↗
19. 10.1002/advs.20240455910.1002/advs.202404559 ↗
20. 10.1016/j.bios.2021.11386810.1016/j.bios.2021.113868 ↗
21. 10.1016/j.bios.2023.11508410.1016/j.bios.2023.115084 ↗
22. 10.1016/j.aca.2022.34058010.1016/j.aca.2022.340580 ↗
23. 10.1016/j.yofte.2023.10346810.1016/j.yofte.2023.103468 ↗
24. 10.1016/j.bios.2019.11149410.1016/j.bios.2019.111494 ↗
25. 10.1166/jbn.2019.276910.1166/jbn.2019.2769 ↗
26. 10.1016/j.snb.2021.13071110.1016/j.snb.2021.130711 ↗